BTG

Companies BTG

News BTG

• IOTA NanoSolutions strengthens its Board through appointment of Dr Julian Gilbert as Non-Executive Director

  The Board of IOTA NanoSolutions announced the appointment of Dr Julian Gilbert as Non-Executive Director of the company. Dr. Gilbert brings over 20 years of commercial and technical experience in the pharmaceutical industry to the role having previously held positions at SmithKline & French, BTG, M more

• Q Chip Ltd announces appointment of Tony Mills

  Q Chip Ltd announced that it has appointed Dr Tony Mills to its Board of Directors. Tony brings a wealth of experience in commercialising technology in the biopharmaceutical sector and as Chief Commercial Officer, will be responsible for generating revenues from Q Chip’s proprietary technology, Q-S more

• BTG plc: Completion of the Acquisition of Protherics PLC

  BTG plc announced that all the conditions to its recommended offer for Protherics PLC have been satisfied and the Acquisition has therefore been completed. Accordingly, 104,044,710 new BTG ordinary shares of 10 pence each issued in connection with the Acquisition were admitted to the Official List a more

Publications BTG

• Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1 [Cell Biology]

  B-cell translocation gene 3 (BTG3) is a member of the antiproliferative BTG/ Transducer of ErbB2 gene family and is induced by genotoxic stress in a p53- and Checkpoint kinase 1 (CHK1)-dependent manner. Down-regulation of BTG3 has been observed in human cancers, suggesting that it plays an important more

• Activation of coagulation and platelets by candidate membranes of implantable devices in a whole blood model without soluble anticoagulant

  Abstract Implantable devices are challenged with thrombus formation at their biomaterial interface. Thus the importance of identifying compatible biomaterials that will help to improve the performance of these devices are becoming increasingly paramount. The aim of this study was to evaluate the more

• Phosphorylation state of a Tob/BTG protein, FOG-3, regulates initiation and maintenance of the Caenorhabditis elegans sperm fate program [Developmental Biology]

  FOG-3, the single Caenorhabditis elegans Tob/BTG protein, directs germ cells to adopt the sperm fate at the expense of oogenesis. Importantly, FOG-3 activity must be maintained for the continued production of sperm that is typical of the male sex. Vertebrate Tob proteins have antiproliferative activ more

Market studies BTG

• Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Panic Disorder Therapeutics market. The report identi more

• Competitive Technologies, Inc. (CTT) - Financial and Strategic SWOT Analysis Review

  Competitive Technologies, Inc., (CTT) is engaged in identifying, developing, and commercializing innovative products technologies in life, electronic, nano, and physical sciences areas. The company provides distribution, patent and technology transfer, selling and licensing services to universities, more

Websites BTG